Current Report Filing (8-k)
September 24 2019 - 8:31AM
Edgar (US Regulatory)
0001097149
False
0001097149
2019-09-24
2019-09-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 24, 2019
_______________________________
ALIGN TECHNOLOGY INC
(Exact name of registrant as specified in its charter)
_______________________________
|
Delaware
|
0-32259
|
94-3267295
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
2820 Orchard Parkway
San Jose,
California
95134
(Address of Principal Executive Offices) (Zip Code)
(408) 470-1000
(Registrant’s telephone number, including area code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
_______________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, $0.0001 par value
|
ALGN
|
The
NASDAQ Stock Market LLC
(NASDAQ Global Market)
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company,indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain Officers; Election of Directors: Appointment
of Certain Officers; Compensatory Arrangement of Certain Officers
Align Technology, Inc. (“Align ” or the "Company")
today announced that Raphael Pascaud, senior vice president of business development and strategy will leave the Company effective
October 1, 2019 and join Sweden based Molnlycke Health Care as executive vice president, Commercial. The Company previously announced
in October 2018 that Mr. Pascaud was reducing his responsibilities and would transition to a part-time position in order to spend
more time with his family in the UK. Mr. Pascaud's new position with Molnlycke requires less travel and will provide him and his
family with more balance. In February 2019, Raj Pudipeddi joined Align as senior vice president and Chief Marketing Officer (CMO),
replacing Mr. Pascaud and Mr. Pudipeddi will now assume all responsibility for business development and strategy upon Mr. Pascaud's
departure. As part of Mr. Pascaud's departure, he will receive a pro-rata bonus of $125,468 US and 12-months' accelerated vesting
of his outstanding restricted stock units (RSUs).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
ALIGN
TECHNOLOGY, INC.
|
|
|
|
|
|
|
By:
|
/s/
Julie Coletti
|
|
|
|
Julie Coletti
|
|
|
|
SVP, Chief Legal
and Regulatory Officer
|
Date: September 24, 2019
Align Technology (NASDAQ:ALGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Align Technology (NASDAQ:ALGN)
Historical Stock Chart
From Apr 2023 to Apr 2024
